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background: ECG signs of myocardial abnormality provide independent prognostic information in asymptomatic aortic stenosis (AS). It is unknown 
if the sum of ECG abnormalities further improves discriminatory power for prediction of cardiovascular outcomes.
methods: Patients with complete 12-lead ECGs in the simvastatin/ezetimibe combination vs. placebo in the Simvastatin and Ezetimibe in Aortic 
Stenosis (SEAS) study were evaluated. Primary endpoint was a composite of 1st myocardial infarction, non-hemorrhagic stroke, heart failure, aortic 
valve replacement or cardiovascular (CV) death. Secondary outcome was CV death. Based on a pre-specified protocol, baseline and annual in-study 
ECGs were categorized as with no or with 1-, 2, or ≥3 ECG abnormalities.
results: 1,446 patients followed for a mean of 4.3 years (6,248 patient-years of follow-up); the composite endpoint occurred in 34.9% (n=505) 
and included 67 (13.3%) CV deaths. In serial-measures analyses, ≥3 ECG abnormalities was, compared to no ECG abnormalities, independently 
predictive of a 2.6-fold (95% CI 2.0 - 3.4) increase in the risk of the primary endpoint and a 3.3-fold (95% CI 1.4 - 7.7) greater risk of 
subsequent CV death (Figure, both p<0.05). Adding number of ECG abnormalities to other important baseline predictors of CV death improved net 
reclassification by 16.2% and the C-index by 3.5% (both p<0.05).
conclusion: 12-lead ECG abnormalities provide incremental prognostic information in initially asymptomatic mild-to-moderate AS.
 
